Skip to main content
. 2020 Jul 25;3(3):248–255. doi: 10.1016/j.cjco.2020.07.017

Table 1.

Patient characteristics with respect to the presence of a comorbidity stratified by hscTnT concentration

Variables n (%) Mean SD SE
hscTnT > 14ng/L 5039 (73.9) 37.05 19.95 0.281
hscTnT ≤ 14ng/L 1783 (26.1) 9.74 2.84 0.067
HTN 5488 (80.5) 22.02 21.94 0.296
RI 3326 (48.7) 33.57 18.50 3.208
Anemia 2852 (41.8) 19.40 18.50 0.346
COPD 2805 (30.5) 28.35 18.09 0.342
DM 2354 (34.5) 26.67 18.64 0.384
Hypothyroidism 2122 (31.1) 21.74 18.73 0.407
Pneumonia 2030 (29.7) 23.51 18.59 0.413
Cancer 1230 (33.7) 18.78 22.71 0.648
PHTN 960 (14) 24.13 12.44 0.401
CVA 844 (12.4) 21.20 18.06 0.622
ASVD 607 (8.9) 27.33 14.01 0.569
SAH 582 (8.5) 23.66 13.10 0.543
PE 539 (7.9) 29.63 12.44 0.536
CM 502 (7.4) 36.01 16.79 0.749
Smoking 148 (2.2) 12.03 8.13 0.668

ASVD, and arteriosclerotic vascular disease; CM, cardiomyopathy; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DM, diabetes mellitus; hscTnT, cardiac troponin T from the high-sensitivity test; HTN, hypertension; PE, pulmonary embolism; PHTN, pulmonary hypertension; RI, renal insufficiency; SAH, subarachnoid hemorrhage; SD, standard deviation; SE, standard error.